Employee Benefit News February 28, 2025
AI drug developer Recursion Pharmaceuticals is considering an Amazon Prime-style subscription model for selling its pipeline of medicines.
The Salt Lake City-based biotech wants to create a system where a U.S. employer could pay, for example, $45 a month per employee to access any medicine Recursion develops regardless of price — provided it’s prescribed by a doctor. If successful, the move has the potential to revolutionize how drugs are sold.
“We’re going to build the Amazon Prime of this industry,” Chief Executive Officer Chris Gibson told Bloomberg at the company’s office in King’s Cross, London. Recursion, which has a market value of $3 billion, has been talking about the proposal with some of its larger investors for several years,...
Today's Sponsors
Today's Sponsor